About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Novel Technique Improves Delivery of Chemotherapy Nanodrugs

by Bidita Debnath on November 30, 2017 at 11:48 PM
Font : A-A+

Novel Technique Improves Delivery of Chemotherapy Nanodrugs

A new method for delivering chemotherapy nanodrugs capable of increasing the drugs' bioavailability and reducing side-effects has been developed by Carnegie Mellon University researchers.

Their study, published online in Scientific Reports, shows that administering an FDA-approved nutrition source prior to chemotherapy can reduce the amount of the toxic drugs that settle in the spleen, liver and kidneys.

Advertisement


Nanodrugs, drugs attached to tiny biocompatible particles, show great promise in treatment of a number of diseases, including cancer. Delivery of these drugs, however, is not very efficient -- only about 0.7 percent of chemotherapy nanodrugs reach their target tumor cells. The remainder are absorbed by other cells, including those in the liver, spleen and kidneys. When the drugs build up in these organs, they cause toxicity and side-effects that negatively impact a patient's quality of life.

Chien Ho, professor of biological sciences at Carnegie Mellon University, and his colleagues have developed a novel way to improve delivery of chemotherapy nanodrugs by using Intralipid®, an FDA-approved nutrition source to temporarily blunt the reticuloendothelial system -- a network of cells and tissues found throughout the body, including in the blood, lymph nodes, spleen and liver, that play an important role in the immune system.
Advertisement

Ho and colleagues tested their technique in a rat model of cancer using three FDA-approved chemotherapy nanodrugs, Abraxane®, Marqibo® and Onivyde®, and one experimental platinum-based anti-cancer nanodrug. In the study, they administered Intralipid one hour before giving the animal a chemotherapy nanodrug. They found that their method reduced the amount of the drug that was found in the liver, spleen and kidneys and reduced the drugs' toxic side-effects. They also found that more of the drug was available to attack tumor cells. Additionally, the Intralipid treatment had no harmful impact on tumor growth or drug efficacy.

The researchers believe that their drug delivery methodology can be applied to a variety of nanodrugs without any modifications to the drugs.

"This methodology could have a major impact in the delivery of nanodrugs not only for patients undergoing chemotherapy for cancer treatment but also to those being treated with nanodrugs for other conditions," said Ho.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Peritoneal Cancer Rhabdomyosarcoma Male Breast Cancer Tumor Lysis Syndrome Neutropenic Sepsis 

Recommended Reading
New Drug Delivery Method Reduces Side Effects of Chemotherapy
Using Intralipid®, an FDA-approved nutrition source to temporarily blunt a network of cells and ......
New Ways to Improve Chemotherapy in Cancer Treatment
Sensing alkylation damage is a major primary defense against chemotherapy drugs, and interfering ......
Why is Chemotherapy So Effective in Testicular Cancer Treatment?
Testicular cancer stem cells are more sensitive to chemotherapy than any other cancer stem cells ......
Antibiotics to Aid Chemotherapy in Treatment of Pancreatic Tumors
Antibiotics to kill bacteria that degrade chemotherapy drug proved effective in reducing ......
Chemotherapy
‘Chemo’ means medicine or ‘drug’; ‘therapy’ means ‘treatment’. Chemotherapy refers to the use of cy...
Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body....
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is consider...
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by c...
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of mal...
Neutropenic Sepsis
Neutropenic sepsis is a potentially life-threatening condition when a patient with low neutrophil co...
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....
Peritoneal Cancer
Peritoneal cancer is a rare cancer that develops in the peritoneum. Peritoneal cancers may be primar...
Rhabdomyosarcoma
Rhabdomyosarcoma is a rare type of cancer affecting the striated muscles. It mostly occurs in ......
Tumor Lysis Syndrome
Tumor lysis syndrome is a collection of metabolic abnormalities due to the tumor cell lysis in patie...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use